CLDI

0.47755.45%
EE

Eric E. Poma

CEO & Director

Dr. Eric E. Poma, Ph.D., is Chief Executive Officer and Director of Calidi Biotherapeutics, Inc. from April 22, 2025. Dr. Poma was the Chief Executive Officer and Chief Scientific Officer of Molecular Templates, Inc. from February 2009 to January 2025 and served as its President and also served as its Interim Chief Financial Officer, Treasurer and Principal Accounting Officer since December 8, 2024. Dr. Poma as the sole director and officer of Nova Cell since June 11, 2025. Dr. Poma founded Private Molecular in February 2009 and has been its Director since inception. As the founder of Private Molecular and in his role as Chief Scientific Officer. Dr. Poma served as Vice President of Business Development and Secretary at CytRx Oncology Corporation (formerly Innovive Pharmaceuticals, Inc.) from March 2005 to September 2008. Dr. Poma served as Assistant Vice President for Business Development of ImClone Systems, Inc. from June 2001 to March 2005, where he was responsible for all licensing and partnership agreements. He also ran the Strategic Planning group at ImClone before his appointment to Business Development. Prior to ImClone, he was a Healthcare and Biotechnology analyst for Eagle Growth Investors from July 2000 to June 2001. He serves as a Director at Molecular Templates, Inc. since August 2017. He held a variety of positions at Bates Healthworld (marketing and contract sales), Rood Research (market research) and Cline, Davis & Mann (pharmaceutical advertising). He holds a PhD in Microbiology and Immunology from the University of North Carolina at Chapel Hill, School of Medicine. He holds an MBA from the Leonard N. Stern School of Business at New York University and B.S. in biology from the University of North Carolina at Chapel Hill.

公司职务